Announcements - The Strateos Blog

Improve Your Laboratory Operations And Build The Path Towards Facility Control

In our continued efforts to push the speed of life sciences, and usher in a new era of global connectivity beyond the capabilities of traditional analog workflows, we are pleased to announce the launch of the Strateos SmartLab Software.

Announcements

Strateos Raises $56 Million in Series B Funding to Expand its SmartLab Platform to Accelerate Life Science Discoveries

Strateos is pleased to announce a $56.1 Million Series B investment led by DCVC and Lux Capital with participation from investors Eli Lilly and Company, Ally Bridge Group, Mack & Co., LLC, Black Diamond Ventures and Castor Ventures.

Announcements

Strateos is Honored to be a Sponsoring Partner with Lesbians Who Tech

The field of science, as in society at large, has always benefited by a diversity of thought; the wellspring of which is the individuals whose distinct life experiences inform their work. Strateos is committed to fostering an environment of representation in our company and in the field of biotechnology. In

Announcements

Paving the Way for Next Generation Experimentation with Self Driving Labs - A Preview of Our Keynote Presentation at the 2021 Smart Labs, Automation & Technology Virtual Summit

Strateos is delighted to have our CEO Mark Fischer-Colbrie deliver a keynote presentation at the upcoming 2021 Smart Labs, Automation, & Technology Summit on May 19th.

Synthetic Biology

The Global Synthetic Biology Conference 2020

In consideration of the fact that one gram of DNA can hold the equivalent of 700 terabytes of information, it’s evident why synthetic biology has the potential for enormous expansion of applications. With the capacity to improve many aspects of our world including healthcare and the environment, Strateos is

Announcements

Launching Strateos's San Diego Region

We're excited to announce we're launching our newest region in San Diego, California.

Announcements

Transcriptic and 3Scan Combine to Form Strateos

The boards of Transcriptic and 3Scan have unanimously approved an agreement to merge companies to combine their considerable engineering capabilities in developing automated systems for chemistry, biology, and tissue analysis. The resulting new company is Strateos

Announcements

3Scan Awarded a Prestigious NIH Grant to Advance its Novel Automated Sectioning and Imaging Technology

San Francisco, CA, Oct. 29, 2018 (GLOBE NEWSWIRE) -- 3Scan, Inc. (3Scan), the world’s leading 3D tissue imaging company has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This grant (R43DK120281) will fund detailed

Announcements

Announcing Our Exciting Collaboration with Eli Lilly in San Diego

Transcriptic has entered into a multi-year collaboration agreement with Eli Lilly and Company to transform how new drugs are discovered. Menlo Park, CA – July 24, 2018 –Transcriptic announced today that it has entered into a multi-year collaboration agreement with Eli Lilly and Company whereby Lilly will license the Transcriptic Common

Announcements

Transcriptic Expands Executive Team To Support Continued Growth

Transcriptic, developer of the first robotic cloud laboratory platform, announced today the appointments of Christopher Krueger as Chief Financial Officer and Kevin Sturdevant as Vice President, Business Operations.

Announcements

Transcriptic Appoints Dr Jeff Finer, M.D., Ph. D. to Board of Directors

Life science veteran Dr. Finer is a Venture Partner with Third Rock Ventures and has 30 years research and clinical experience. Transcriptic, the first robotic cloud laboratory platform, today announced the addition of Jeff Finer, M.D., Ph.D. to the company’s Board of Directors. Dr. Finer is currently

Synthetic Biology

Transcriptic and Ginkgo Bioworks Selected By DARPA To Accelerate Biological Design with $9.5M Award

Synergistic Discovery and Design Program to facilitate creation of a cloud-based experimental design platform and open data exchange.

Synthetic Biology

Announcing our collaboration with Ginkgo Bioworks To Accelerate Automation in Organism Design

Five year, $10 million+ deal with robotic cloud lab will double Ginkgo’s foundry output; increase scale of its synthetic biology innovation